Circle8 Group Inc. (CIRC)
CIRC trades on Nasdaq in Industrials, Biotechnology: Laboratory Analytical Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.3611
-19.38% on the day
Market cap
$42.4M
Nano cap
Revenue · 2025
$435.9M
-1.5% on 2024
Net income · 2025
-$59.4M
-13.6% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | CIRC on Nasdaq |
| Sector | Industrials |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Country | United States |
| IPO year | 2024 |
| SEC CIK | 0001605888 |
| SEC industry code | Services-Help Supply Services |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $435.9M |
| Net income | -$59.4M |
| Operating income | -$50.2M |
| Net margin | -13.6% |
| Operating margin | -11.5% |
| Revenue growth | -1.5% |
| Cash | $81K |
| Total assets | $113.2M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.1× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B7 | 2026-10-07 |
| Latest annual report | 10-K | 2026-04-15 |
| Latest quarterly / interim | 10-Q | 2026-08-19 |
| Latest current report | 8-K | 2026-09-11 |
| Latest proxy | DEF 14A | 2025-11-04 |
Source: SEC EDGAR submissions feed, 315 recent filings. All filings on EDGAR.
Peers in Biotechnology: Laboratory Analytical Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| RPID | Rapid Micro Biosystems Inc. | $0.8738 | -0.57% | $43.8M |
| PRPO | Precipio Inc. | $22.59 | 0.00% | $40.4M |
| HBIO | Harvard Bioscience Inc. | $8.27 | +0.36% | $37.6M |
| BNGO | Bionano Genomics Inc. | $1.36 | +1.11% | $16.0M |
| SEER | Seer Inc. | $2.11 | -1.86% | $116.8M |
| ASTC | Astrotech Corporation (DE) | $6.06 | -1.94% | $12.2M |
| QTRX | Quanterix Corporation | $3.15 | -0.32% | $149.0M |
| LAB | Standard BioTools Inc. | $0.6589 | +0.17% | $260.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier